Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 11 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Immunome Inc. | 690,704 | reported | 27 Mar 2026 | tx 14+2,340,272−200,000 |
| SEATTLE GENETICS INC /WA | 672,510 | reported | 12 May 2022 | tx 1263+6,554,351−6,680,885 |
| Nurix Therapeutics, Inc. | 17,500 | reported | 05 May 2022 | tx 2+52,500 |
| Mirna Therapeutics, Inc. | 10,000 | reported | 29 Jun 2016 | tx 2+22,000 |
| Ultragenyx Pharmaceutical Inc. | 2,550 | reported | 10 Aug 2020 | tx 22+91,550−59,750 |
| Talaris Therapeutics, Inc. | 0 | reported | 28 Oct 2025 | tx 6+51,800−51,800 |
| ALDER BIOPHARMACEUTICALS INC | 0 | reported | 22 Oct 2019 | tx 29+143,745−245,455 |
| Shattuck Labs, Inc. | 0 | reported | 22 May 2026 | tx 7+478,421−128,054 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 May 2026 | GRANT_AWARD | Shattuck Labs, Inc. | 128,054 | 1.08 USD | |
| 22 May 2026 | EXERCISE | Shattuck Labs, Inc. | 128,054 | — | deriv |
| 27 Mar 2026 | PURCHASE | Immunome Inc. | 25,450 | 19.67 USD | |
| 30 Dec 2025 | PURCHASE | Immunome Inc. | 4,729 | 21.15 USD | |
| 19 Dec 2025 | GIFT | Immunome Inc. | 200,000 | 0.00 USD | |
| 19 Dec 2025 | PURCHASE | Immunome Inc. | 7,278 | 20.48 USD | |
| 18 Dec 2025 | PURCHASE | Immunome Inc. | 46,511 | 21.50 USD | |
| 28 Oct 2025 | OTHER | Talaris Therapeutics, Inc. | 20,000 | — | deriv |
| 28 Oct 2025 | OTHER | Talaris Therapeutics, Inc. | 16,800 | — | deriv |
| 28 Oct 2025 | OTHER | Talaris Therapeutics, Inc. | 15,000 | — | deriv |
| 25 Aug 2025 | GRANT_AWARD | Shattuck Labs, Inc. | 128,054 | 0.87 USD | |
| 25 Aug 2025 | GRANT_AWARD | Shattuck Labs, Inc. | 128,054 | — | deriv |
| 29 Jul 2025 | GRANT_AWARD | Immunome Inc. | 800,000 | 0.00 USD | deriv |
| 14 Jul 2025 | GRANT_AWARD | Shattuck Labs, Inc. | 33,150 | 0.00 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | Talaris Therapeutics, Inc. | 16,800 | 0.00 USD | deriv |
| 26 Mar 2025 | PURCHASE | Immunome Inc. | 137,100 | 7.29 USD | |
| 31 Jan 2025 | PURCHASE | Immunome Inc. | 150,000 | 7.75 USD | |
| 21 Nov 2024 | PURCHASE | Immunome Inc. | 66,057 | 9.54 USD | |
| 22 Nov 2024 | PURCHASE | Immunome Inc. | 33,943 | 9.78 USD | |
| 09 Aug 2024 | GRANT_AWARD | Immunome Inc. | 800,000 | 0.00 USD | deriv |
| 21 Jun 2024 | GRANT_AWARD | Shattuck Labs, Inc. | 27,700 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Talaris Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 20 May 2024 | PURCHASE | Immunome Inc. | 79,566 | 13.91 USD | |
| 21 May 2024 | PURCHASE | Immunome Inc. | 20,434 | 13.78 USD | |
| 06 Mar 2024 | GRANT_AWARD | Shattuck Labs, Inc. | 33,409 | 0.00 USD | deriv |